Well yes they do have a legal responsibility, here are some guidelines:
It needs to be done if its appropriate and there are no other viable official alternatives etc.
Weighing up of cost/benefit analysis is also a consideration to the patient etc.
Sure some Docs wouldn't be prepared to do it...but it is allowed in light of the above points and considerations.
Check out below references for additional info.
REFERENCES
1) https://www.mdanational.com.au/advice-and-support/library/articles-and-case-studies/2019/11/off-label-prescribing-what-you-need-to-know#:~:text=In%20summary,exhausted%2C%20not%20tolerated%20or%20unsuitable.
2) https://www.anzca.edu.au/resources/professional-documents/guidelines/use-of-off-label-or-drugs-beyond-licence-in-pain-m
- Forums
- ASX - By Stock
- PAR
- PAR, some place in QLD and the (magical) possible pathway...
PAR, some place in QLD and the (magical) possible pathway..., page-23
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NVA
Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.5¢ |
Change
-0.010(3.77%) |
Mkt cap ! $89.19M |
Open | High | Low | Value | Volume |
27.0¢ | 27.0¢ | 25.5¢ | $162.7K | 620.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 25008 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 34768 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 25008 | 0.255 |
8 | 215150 | 0.250 |
6 | 109763 | 0.245 |
7 | 91034 | 0.240 |
2 | 54200 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 34768 | 1 |
0.270 | 500 | 1 |
0.275 | 6347 | 2 |
0.290 | 14580 | 3 |
0.295 | 10000 | 2 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |